✦ LIBER ✦

A phase I–II study of combination therapy with thymidine and cytosine arabinoside

✍ Scribed by R. Fram; P. Major; E. Egan; P. Beardsley; D. Rosenthal; D. Kufe

Book ID: 104687214
Publisher: Springer
Year: 1983
Tongue: English
Weight: 391 KB
Volume: 11
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00257416

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I-II clinical and pharmacologic st

Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia

✍ Hagop M. Kantarjian; Elihu H. Estey; William Plunkett; Michael J. Keating; Ronal 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 947 KB

Phase II study of carboplatin and cytosi

Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma

✍ N. H. Mulder; D. Th. Sleijfer; E. G. E. de Vries; H. Schraffordt Koops; P. H. B. 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 222 KB

Phase I study of high-dose cytosine arab

Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies

✍ Bayard L. Powell; Hyman B. Muss; Robert L. Capizzi; Mary E. Caponera; Douglas R. 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 273 KB

The treatment of poor prognosis myelomat

The treatment of poor prognosis myelomatosis with a cytosine arabinoside containing combination

✍ D. J. Dodwell; I. G. McGill 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

During the last 14 years a combination of cytosine arabinoside, vincristine, cyclophosphamide and prednisolone (ARA-COP) has been evaluated in 37 consecutive patients (M:F 25: 12) presenting with stage 3A (1 1) or stage 3B (26) multiple myeloma according to the staging system of Dune and Salmon (197

High-dose cytosine arabinoside and dauno

High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the southeastern cancer study group

✍ Hillard M. Lazarus; W. Ralph Vogler; C. Patrick Burns; Elliott F. Winton 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

Phase-II study of treatment of refractor

Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrine

✍ U. Jehn; V. Heinemann 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 261 KB